PHOSPHO-SODA ORAL SOLUTION

Product Information

Registration Status: Active

PHOSPHO-SODA ORAL SOLUTION is approved to be sold in Singapore with effective from 2003-03-17. It is marketed by EURO ASIA MEDICO PTE LTD, with the registration number of SIN12230P.

This product contains Sodium Phosphate 0.9g/5ml in the form of SOLUTION. It is approved for ORAL use.

This product is manufactured by Casen Recordati S.L. in SPAIN.

It is a Pharmacy Only Medicine that can be obtained from a pharmacist at a retail pharmacy.

Sodium Phosphate

Description

Sodium phosphate is a saline laxative that is thought to work by increasing fluid in the small intestine. It usually results in a bowel movement after 30 minutes to 6 hours.

Indication

Used to treat constipation or to clean the bowel before a colonoscopy [FDA Label].

Mechanism of Action

Sodium phosphate is thought to work by increasing the amount of solute present in the intestinal lumen thereby creating an osmotic gradient which draws water into the lumen [A19446].

Pharmacokinetics

Absorption
Tmax for phosphate absorption with orally administered liquid sodium phosphate is 1-3h [A19448].
Distribution
Metabolism
Elimination

Toxicity

Intamuscular LD50 of 250mg/kg and oral LD50 of 8290 mg/kg reported in rats [L799]. Phosphate toxicity is likely due to the disturbance of other electrolytes when phosphate levels are high, producing symptoms including tetany, dehydration, hypotension, tachycardia, hyperpyrexia, cardiac arrest and coma [A19449]. Risk of raising phosphate levels through use of sodium phosphate appears to be higher in smaller patients [A19448].

Active Ingredient/Synonyms

Sodium orthophosphate | Sodium phosphate monobasic | Sodium phosphate monobasic (anhydrate) | Sodium phosphate, unspecified | Sodium phosphates | Sodium phosphate |


Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.

References

  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank